Human medicines European public assessment report (EPAR): Gardasil, human papillomavirus vaccine [types 6, 11, 16, 18] (recombinant, adsorbed), Date of authorisation: 20/09/2006, Revision: 52, Status: Authorised

Human medicines European public assessment report (EPAR): Gardasil, human papillomavirus vaccine [types 6, 11, 16, 18] (recombinant, adsorbed), Date of authorisation: 20/09/2006, Revision: 52, Status: Authorised

Human medicines European public assessment report (EPAR): Herwenda, trastuzumab, Date of authorisation: 15/11/2023, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR): Herwenda, trastuzumab, Date of authorisation: 15/11/2023, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR): Elevidys, delandistrogene moxeparvovec, Date of refusal: 24/09/2025, Status: Refused

Human medicines European public assessment report (EPAR): Elevidys, delandistrogene moxeparvovec, Date of refusal: 24/09/2025, Status: Refused

Human medicines European public assessment report (EPAR): Imvanex, smallpox and monkeypox vaccine (Live Modified Vaccinia Virus Ankara), Date of authorisation: 31/07/2013, Revision: 31, Status: Authorised

Human medicines European public assessment report (EPAR): Imvanex, smallpox and monkeypox vaccine (Live Modified Vaccinia Virus Ankara), Date of authorisation: 31/07/2013, Revision: 31, Status: Authorised

Human medicines European public assessment report (EPAR): Diacomit, stiripentol, Date of authorisation: 03/01/2007, Date of refusal: 11/02/2009, Revision: 20, Status: Authorised

Human medicines European public assessment report (EPAR): Diacomit, stiripentol, Date of authorisation: 03/01/2007, Date of refusal: 11/02/2009, Revision: 20, Status: Authorised

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.